RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylation

Cell Cycle

Volumn 13, Issue 20, 2014, Pages 3222-3231

  Wu, Bo Kuan ^a   Mei, Szu Chieh ^a   Brenner, Charles ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Chromatin; DNA methylation; DNMT1; RFTS domain; Tumorigenicity

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DUOX1 PROTEIN; PROTEIN; SATELLITE 2; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1;

ALLELE; ARTICLE; CARCINOGENICITY; CATALYST; CELL INVASION; CELL PROLIFERATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CPG ISLAND; DNA BINDING; DNA METHYLATION; EPIGENETICS; EPITHELIUM CELL; FOCAL HYPERMETHYLATION; GENE SEQUENCE; GLOBAL HYPOMETHYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPLICATION FOCI TARGETING SEQUENCE; TRANSCRIPTION INITIATION SITE; UPREGULATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GENETICS; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY;

CELL LINE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; HUMANS; IMMUNOBLOTTING;

EID: 84912099856     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.950886     Document Type: Article

References (65)

1. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6:597-610; PMID:16136652; http://dx.doi.org/10.1038/nrg1655
2. Issa J-P. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004; 4:988-93; PMID:15573120
3. Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer 2004; 4:707-17; PMID:15343277; http://dx.doi.org/10.1038/nrc1432
4. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415- 28; PMID:12042769
5. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 1988; 48:1159-61; PMID:3342396
6. Eden A, Gaudet F, Waghmare A, Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300:455; PMID:12702868; http://dx.doi.org/10.1126/science. 1083557
7. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21:5400-13; PMID:12154403; http://dx.doi.org/10.1038/sj. onc.1205651
8. Christman JK, SheikhnejadG,MarascoCJ, Sufrin JR. 5- Methyl-2'-deoxycytidine in single-strandedDNA can act in cis to signal de novo DNA methylation. Proc Natl Acad Sci USA 1995; 92:7347-51; PMID:7638194; http://dx.doi.org/10.1073/pnas.92.16.7347
9. Pradhan S, Talbot D, Sha M, Benner J, Hornstra L, Li E, Jaenisch R, Roberts RJ. Baculovirus-mediated expression and characterization of the full-length murine DNA methyltransferase. Nucleic Acids Res 1997; 25:4666-73; PMID:9358180; http://dx.doi.org/10.1093/nar/25.22.4666
10. Jair K-W, Bachman KE, Suzuki H, Ting AH, Rhee I, Yen R-WC, Baylin SB, Schuebel KE. De novo CpG island methylation in human cancer cells. Cancer Res 2006; 66:682-92; PMID:16423997; http://dx.doi.org/10.1158/0008-5472.CAN-05-1980
11. el-DeiryWS,Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, Baylin SB. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 1991; 88:3470-4; PMID:2014266; http://dx.doi.org/10.1073/pnas.88.8.3470
12. Belinsky SA, Nikula KJ, Baylin SB, Issa JP. Increased cytosine DNA-methyltransferase activity is targetcell- specific and an early event in lung cancer. Proc Natl Acad Sci USA 1996; 93:4045-50; PMID: 8633014; http://dx.doi.org/10.1073/pnas.93.9.4045
13. Lin R-K, Hsu H-S, Chang J-W, Chen C-Y, Chen JT, Wang Y-C. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 2007; 55:205-13; PMID:17140695; http://dx.doi.org/10.1016/j. lungcan.2006.10.022
14. Kimura F, Seifert H-H, Florl AR, Santourlidis S, Steinhoff C, Swiatkowski S, Mahotka C, Gerharz CD, Schulz WA. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int J Cancer 2003; 104:568- 78; PMID:12594811; http://dx.doi.org/10.1002/ ijc.10988
15. Wu J, Issa JP, Herman J, Bassett DE, Nelkin BD, Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 1993; 90:8891-5; PMID:8415627; http://dx.doi.org/ 10.1073/pnas.90.19.8891
16. Bakin AV, Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 1999; 283:387-90; PMID:9888853; http://dx.doi.org/10.1126/science.283.5400.387
17. Biniszkiewicz D, Gribnau J, Ramsahoye B, Gaudet F, Eggan K, Humpherys D, Mastrangelo M-A, Jun Z, Walter J, Jaenisch R. Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol 2002; 22:2124- 35; PMID:11884600; http://dx.doi.org/10.1128/ MCB.22.7.2124-2135.2002
18. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992; 69:915-26; PMID:1606615; http://dx.doi.org/10.1016/0092-8674(92)90611-F
19. Gaudet F. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489-92; PMID: 12702876; http://dx.doi.org/10.1126/science.1083558
20. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Coco Lo F, Kouzarides T, Nervi C, et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002; 295:1079- 82; PMID:11834837; http://dx.doi.org/10.1126/ science.1065173
21. Viré E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden J-M, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439:871-4; http://dx.doi.org/10.1038/ nature04431
22. Esteve PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, Carey MF, Pradhan S. Direct interaction between DNMT1 and G9a coordinates DNA and histonemethylation during replication. Genes Dev 2006; 20:3089-103; PMID:17085482; http://dx. doi.org/10.1101/gad.1463706
23. Smallwood A, Esteve PO, Pradhan S, Carey M. Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 2007; 21:1169- 78; PMID:17470536; http://dx.doi.org/10.1101/ gad.1536807
24. Chuang LS. Human DNA-(Cytosine-5) methyltransferase- PCNA complex as a target for p21WAF Science 1997; 277:1996-2000; PMID:9302295; http://dx.doi.org/10.1126/science.277.5334.1996
25. Hervouet E, Lalier L, Debien E, Cheray M, Geairon A, Rogniaux H, Loussouarn D, Martin SA, Vallette FM, Cartron P-F. Disruption of Dnmt1/PCNA/ UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS ONE 2010; 5:e11333; PMID:20613874; http://dx.doi.org/10.1371/journal. pone.0011333
26. Pradhan S, Kim G-D. The retinoblastoma gene product interacts with maintenance human DNA (cytosine- 5) methyltransferase and modulates its activity. EMBO J 2002; 21:779-88; PMID:11847125; http://dx.doi.org/10.1093/emboj/21.4.779
27. Leonhardt H, Page AW, Weier HU, Bestor TH. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 1992; 71:865-73; PMID:1423634; http://dx.doi.org/10.1016/0092-8674(92)90561-P
28. Margot JB, Aguirre-Arteta AM, Di Giacco BV, Pradhan S, Roberts RJ, Cardoso MC, Leonhardt H. Structure and function of the mouse DNA methyltransferase gene: Dnmt1 shows a tripartite structure. J Mol Biol 2000; 297:293-300; PMID:10715201; http://dx.doi.org/10.1006/jmbi.2000.3588
29. Bostick M, Kim JK, Estéve P-O, Clark A, Pradhan S, Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007; 317:1760-4; PMID:17673620; http://dx.doi.org/10.1126/science.1147939
30. Sharif J, Muto M, Takebayashi S-I, Suetake I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T, Okamura K, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007; 450:908- 12; PMID:17994007; http://dx.doi.org/10.1038/ nature06397
31. Syeda F, Fagan RL, Wean M, Avvakumov GV, Walker JR, Xue S, Dhe-Paganon S, Brenner C. The replication focus targeting sequence (RFTS) domain is a DNA-competitive inhibitor of Dnmt J Biol Chem 2011; 286:15344-51; PMID:21389349; http://dx.doi.org/10.1074/jbc.M110.209882
32. Takeshita K, Suetake I, Yamashita E, Suga M, Narita H, Nakagawa A, Tajima S. Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1). Proc Natl Acad Sci USA 2011; 108:9055-9; PMID:21518897; http://dx.doi.org/10.1073/pnas.1019629108
33. Hashimoto H, Liu Y, Upadhyay AK, Chang Y, Howerton SB, Vertino PM, Zhang X, Cheng X. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res 2012; 40:4841-9; PMID:22362737; http://dx.doi.org/10.1093/nar/gks155
34. Berkyurek AC, Suetake I, Arita K, Takeshita K, Nakagawa A, Shirakawa M, Tajima S. The DNA methyltransferase Dnmt1 directly interacts with the SET and RING finger-associated (SRA) domain of the multifunctional protein Uhrf1 to facilitate accession of the catalytic center to hemi-methylated DNA. J Biol Chem 2014; 289:379-86; PMID:24253042; http://dx.doi.org/10.1074/jbc.M113.523209
35. Bashtrykov P, Jankevicius G, Jurkowska RZ, Ragozin S, Jeltsch A. The UHRF1 protein stimulates the activity and specificity of the maintenance DNA methyltransferase DNMT1 by an allosteric mechanism. J Biol Chem 2014; 289:4106-15; PMID: 24368767; http://dx.doi.org/10.1074/jbc.M1528893
36. Bashtrykov P, Rajavelu A, Hackner B, Ragozin S, Carell T, Jeltsch A. Targeted mutagenesis results in an activation of DNA methyltransferase 1 and confirms an autoinhibitory role of its RFTS domain. Chembiochem 2014; 15:743-8; PMID:24532244; http://dx.doi.org/10.1002/cbic.201300740
37. Song J, Rechkoblit O, Bestor TH, Patel DJ. Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 2011; 331:1036-40; PMID:21163962; http://dx.doi.org/10.1126/science.1195380
38. Klein CJ, Botuyan M-V, Wu Y, Ward CJ, Nicholson GA, Hammans S, Hojo K, Yamanishi H, Karpf AR, Wallace DC, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011; 43:595-600; PMID:21532572; http://dx.doi.org/10.1038/ng.830
39. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW, et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a fullmalignant phenotype on human bronchial epithelial cells. Cancer Res 2006; 66:2116-28; PMID:16489012; http://dx.doi.org/10.1158/0008-5472.CAN-05-2521
40. Damiani LA, Yingling CM, Leng S, Romo PE, Nakamura J, Belinsky SA. Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells. Cancer Res 2008; 68:9005-14; PMID:18974146; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1276
41. Kim DH, Nelson HH, Wiencke JK, Christiani DC, Wain JC, Mark EJ, Kelsey KT. Promoter methylation of DAP-kinase: Association with advanced stage in non-small cell lung cancer. Oncogene 2001; 20:1765-70; PMID:11313923; http://dx.doi.org/ 10.1038/sj.onc.1204302
42. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, Belinsky SA. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 2004; 64:3844-8; PMID:15172992; http://dx.doi.org/ 10.1158/0008-5472.CAN-03-2119
43. Luxen S, Belinsky SA, Knaus UG. Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. Cancer Res 2008; 68:1037-45; PMID:18281478; http://dx.doi.org/10.1158/0008- 5472.CAN-07-5782
44. Khulan B. Comparative isoschizomer profiling of cytosine methylation: The HELP assay. Genome Res 2006; 16:1046-55; PMID:16809668; http://dx.doi.org/10.1101/gr.5273806
45. Thompson RF, Reimers M, Khulan B, Gissot M, Richmond TA, Chen Q, Zheng X, Kim K, Greally JM. An analytical pipeline for genomic representations used for cytosine methylation studies. Bioinformatics 2008; 24:1161-7; PMID:18353789; http://dx.doi.org/10.1093/bioinformatics/btn096
46. Magaña AA, Wrobel K, Caudillo YA, Zaina S, Lund G, Wrobel K. High-performance liquid chromatography determination of 5-methyl-2"-deoxycytidine, 2-"deoxycytidine, and other deoxynucleosides and nucleosides in DNA digests. Anal Biochem 2008; 374:378-85; http://dx.doi.org/10.1016/j.ab.2011.026
47. Easwaran HP, Schermelleh L, Leonhardt H, Cardoso MC. Replication-independent chromatin loading of Dnmt1 during G2 and M phases. EMBO Rep 2004; 5:1181-6; PMID:15550930; http://dx.doi.org/10.1038/ sj.embor.7400295
48. Schneider K, Fuchs C, Dobay A, Rottach A, Qin W, Wolf P, Alvarez-Castro JM, Nalaskowski MM, Kremmer E, Schmid V, et al. Dissection of cell cycledependent dynamics of Dnmt1 by FRAP and diffusion- coupled modeling. Nucleic Acids Res 2013; 41:4860-76; PMID:23535145; http://dx.doi.org/ 10.1093/nar/gkt191
49. Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011; 331:593-6; PMID:21233348; http://dx.doi.org/10.1126/ science.1200801
50. Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, Vogelstein B, Baylin SB, Schuebel KE. CpG methylation is maintained in human cancer cells lacking DNMT Nature 2000; 404:1003-7; PMID:10801130; http://dx.doi.org/10.1038/35010000
51. Espada J. Human DNA methyltransferase 1 is required for maintenance of the histone H3 modification pattern. J Biol Chem 2004; 279:37175-84; PMID:15220328; http://dx.doi.org/10.1074/jbc.M404842200
52. Fellinger K, Rothbauer U, Felle M, Längst G, Leonhardt H. Dimerization of DNA methyltransferase 1 is mediated by its regulatory domain. J Cell Biochem 2009; 106:521-8; PMID:19173286; http://dx.doi.org/10.1002/jcb.22071
53. Felle M, Joppien S, Nemeth A, Diermeier S, Thalhammer V, Dobner T, Kremmer E, Kappler R, Langst G. The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF Nucleic Acids Res 2011; 39:8355-65; PMID:21745816; http://dx.doi.org/ 10.1093/nar/gkr528
54. Lee C-F,OuDS-C, Lee S-B,Chang L-H, Lin R-K, Li YS, Upadhyay AK, Cheng X, Wang Y-C, Hsu H-S, et al. hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest 2010; 120:2920-30; PMID:20592467; http://dx.doi.org/10.1172/JCI42275
55. Unoki M, Daigo Y, Koinuma J, Tsuchiya E, Hamamoto R, Nakamura Y. UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer 2010; 103:217-22; PMID:20517312; http://dx.doi.org/ 10.1038/sj.bjc.6605717
56. Daskalos A, Oleksiewicz U, Filia A, Nikolaidis G, Xinarianos G, Gosney JR, Malliri A, Field JK, Liloglou T. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer 2011; 117:1027-37; PMID:21351083; http://dx.doi.org/10.1002/cncr.25531
57. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81:197-205; PMID:7537636; http://dx.doi.org/10.1016/0092-8674(95)90329-1
58. Suzuki M, Sunaga N, Shames DS, Toyooka S, Gazdar AF, Minna JD. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 2004; 64:3137-43; PMID:15126351; http://dx.doi.org/10.1158/0008-5472.CAN-03-3046
59. Ramchandani S, MacLeod AR, Pinard M, Hofe von E, Szyf M. Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Natl Acad Sci USA 1997; 94:684-9; PMID:9012845; http://dx.doi.org/10.1073/pnas.94.2.684
60. McCabe MT, Low JA, Daignault S, Imperiale MJ, Wojno KJ, Day ML. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res 2006; 66:385- 92; PMID:16397253; http://dx.doi.org/10.1158/ 0008-5472.CAN-05-2020
61. Datta J, Ghoshal K, Denny WA, Gamage SA, Brooke DG, Phiasivongsa P, Redkar S, Jacob ST. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation. Cancer Res 2009; 69:4277-85; PMID:19417133; http://dx.doi.org/10.1158/0008-5472.CAN-08-3669
62. Szyf M. Targeting DNA methylation in cancer. Ageing Res Rev 2003; 2:299-328; PMID:12726777; http://dx.doi.org/10.1016/S1568-1637(03)00012-6
63. Loriot A. Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J Biol Chem 2006; 281:10118-26; PMID:16497664; http://dx.doi.org/10.1074/jbc.M510469200
64. Yaqinuddin A, Qureshi SA, Qazi R, Farooq S, Abbas F. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness. J Urol 2009; 182:756-61; PMID:19539327; http://dx.doi.org/10.1016/j.juro.2009.03.082
65. Morey Kinney SR, Moser MT, Pascual M, Greally JM, Foster BA, Karpf AR. Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer. Mol Cell Biol 2010; 30:4159-74; PMID:20584988;